Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy

Supportive Care in Cancer

Volumn 4, Issue 1, 1996, Pages 31-33

  Cascinu, S ^a   Casadei, V ^a   Del Ferro, E ^a   Alessandroni, P ^a   Catalano, G ^a  

^a SAN SALVATORE HOSPITAL   (Italy)

Author keywords

Bone m tastases; Pamidronate

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PAIN; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PALLIATIVE CARE; PROSPECTIVE STUDIES;

EID: 0029686172     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01769872     Document Type: Article

References (13)

1. Canfiled RE (1987) Etidronate disodium: a new therapy for hypercalcemia of malignancy. Am J Med 82:1-78
2. Coleman RE. Woll PJ, Miles M, Scrivener W, Rubens RD (1988) Treatment of bone metastases from breast cancer with pamidronate. Br J Cancer 58:621-625
3. Fast DK, Felix R, Dowse C (1978) The effects of disphosphonates on the growth and glycohsis of connective-tissue cells in culture. Biochem J 172:97-107
4. Felix R, Russel RGG, Fleisch H (1976) The effect of several bisphosphonates on acid phosphohydrolases and other lysosomal enzymes. Biochim Biophys Acta 429:429-438
5. Felix R, Better JD, Fleisch H (1981) Effect of disphosphonates on the synthesis of prostaglandins in cultured calvaria cells. Tissue Int 33:549-552
6. Fitton A, McTavish A (1991) Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drug 41:289-318
7. Glantz SA (1992) Primer of biostatistics. 4th edn. McGraw Hill, New York
8. Holten-Verzantvoorta TM van. Zwinderman AH, Aaronson NK, Hermans J, Hemmerik B van, Dam FSAM van, der Bos B van, Bijvoet OLM, Lleton FJ (1991) The effects of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 27:544-549
9. Kanis JA (1987) Clodronate. A new perspective in the treatment of neoplastic bone disease. Bone 8:1-86
10. Nolkins H (1987) Tumorhandbuch, vol 3. Pathologie und Klinik der menschlichen Tumoren. Urban & Schwarzenberg, München, pp 1030-1033
11. Thiebaud D, Leyvraz S, Fliedner V von, Perey L, Cornu P, Thibaud S, Burckardt P (1991) Treatment of bone metastases from breast cancer and myeloma with pamidronate. Eur J Cancer 27:37-41
12. Thurlimann B (1994) Progress in the treatment and palliation of advanced breast cancer: does the dose of pamidronate determine its effect? Ann Oncol 5 [Suppl7]:45-47
13. Tyrrel CJ (1994) Role of pamidronate in the management of bone metastases from breast cancer: results of a non-comparative multicenter phase II trial. Ann Oncol 5 [Suppl 7]: 37-40